Pete Vonier

Pete Vonier is a seasoned professional in clinical research, currently serving as the Managing Partner at OWL Oncology Research, LLC since July 2010, and as a CRA Consultant at Vonier Research Consulting, LLC since November 2008. With extensive experience in clinical research monitoring, Pete has previously held consulting roles at prominent organizations including IQVIA and Cmed Clinical Services, along with direct CRA positions at Catalyst and Veristat, Inc. Notable previous positions include Senior CRA at Takeda Global Research and Development and Lead CRA at TAP Pharmaceutical Products. Pete Vonier earned a PhD in Biology from Tulane University and a BS in Molecular and Cellular Biology from the University of Arizona.